Literature DB >> 12832003

Effect of stimulation intensity and botulinum toxin isoform on rat bladder strip contractions.

Christopher P Smith1, Timothy B Boone, William C de Groat, Michael B Chancellor, George T Somogyi.   

Abstract

The present experiments compared the inhibitory effects of botulinum toxin A (BoNT-A) and botulinum toxin D (BoNT-D) on neurally evoked contractions of rat bladder strips. We examined the effect of fatigue (trains of 100 shocks at 20Hz every 20s for 10min) followed by non-fatigue stimulation (trains of 100 shocks at 20Hz every 100s for 20min) on the onset of effect and potency of the two toxins. For non-fatigue experiments, strips were untreated (n=4); or incubated with 1.36nM BoNT-A (n=4). During fatigue experiments, strips were untreated (n=5); or treated with either 1.36nM BoNT-A (n=6) or 0.8nM BoNT-D (n=6). In non-fatigue experiments, BoNT-A produced significant decreases in contractile area after 1h of stimulation compared to untreated strips (P<0.05). After three series of fatigue stimulation, differences in recovery amplitude and area between untreated versus BoNT-A, and untreated versus BoNT-D bladder strips, were statistically significant (P<0.05). The onset of inhibitory effect was quicker in BoNT-D-treated strips, as a significant reduction (P<0.05) in recovery of contractile area was observed after 1h of stimulation compared to both untreated and BoNT-A-treated preparations. In addition, treated (BoNT-A and BoNT-D) and untreated bladder strips responded similarly to atropine, suggesting that the effects of BoNT result from inhibition of both acetylcholine and ATP release. Our results demonstrate that BoNT-D may be a more effective agent to inhibit transmitter release from autonomic nerves of the rat lower urinary tract. Moreover, in our hands, non-fatigue stimulation is as effective as fatigue stimulation in inhibiting bladder strip contractions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832003     DOI: 10.1016/s0361-9230(03)00114-x

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  19 in total

Review 1.  Integrative control of the lower urinary tract: preclinical perspective.

Authors:  William C de Groat
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

2.  Characterizing the Bladder's Response to Onabotulinum Toxin Type A Using a Rat Model.

Authors:  Alexis A Dieter; Jennifer M Wu; Nazema Y Siddiqui; Danielle J Degoski; Jillene M Brooks; Paul C Dolber; Matthew O Fraser
Journal:  Female Pelvic Med Reconstr Surg       Date:  2016 Nov/Dec       Impact factor: 2.091

Review 3.  Ten years single surgeon experience with botulinum toxin in the urinary tract; clinical observations and research discovery.

Authors:  Michael B Chancellor
Journal:  Int Urol Nephrol       Date:  2009-07-02       Impact factor: 2.370

Review 4.  Neural control of lower urinary tract and targets for pharmacological therapy.

Authors:  Maria Augusta T Bortolini; Andreisa P M Bilhar; Rodrigo A Castro
Journal:  Int Urogynecol J       Date:  2014-07-08       Impact factor: 2.894

Review 5.  Experience with botulinum toxin type A in the treatment of neurogenic detrusor overactivity in clinical practice.

Authors:  Stephanie Knuepfer; Klaus-Peter Juenemann
Journal:  Ther Adv Urol       Date:  2014-02

6.  Excitatory effect of acotiamide on rat and human bladder: Implications for underactive bladder treatment.

Authors:  Nishant Singh; Shinsuke Mizoguchi; Takahisa Suzuki; Irina Zabbarova; Youko Ikeda; Anthony Kanai; Christopher Chermansky; Naoki Yoshimura; Pradeep Tyagi
Journal:  Life Sci       Date:  2020-08-03       Impact factor: 5.037

Review 7.  Drug Insight: biological effects of botulinum toxin A in the lower urinary tract.

Authors:  Michael B Chancellor; Clare J Fowler; Apostolos Apostolidis; William C de Groat; Christopher P Smith; George T Somogyi; K Roger Aoki
Journal:  Nat Clin Pract Urol       Date:  2008-05-06

8.  Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury.

Authors:  Christopher P Smith; David A Gangitano; Alvaro Munoz; Nilson A Salas; Timothy B Boone; K Roger Aoki; Joseph Francis; George T Somogyi
Journal:  Neurochem Int       Date:  2007-11-26       Impact factor: 3.921

Review 9.  A case for botulinum toxin-A in idiopathic bladder overactivity.

Authors:  Christopher P Smith; George T Somogyi; Michael B Chancellor; Rodney A Appell
Journal:  Curr Urol Rep       Date:  2004-12       Impact factor: 2.862

10.  Preclinical assessment of potential interactions between botulinum toxin and neuromodulation for bladder micturition reflex.

Authors:  Xin Su; Angela Nickles; Dwight E Nelson
Journal:  BMC Urol       Date:  2015-06-09       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.